STAT

A year in women’s health: 10 STAT stories worth reading

Some of our best stories of the year have been about issues affecting women's health. Here are a few.

It’s been a big year for women in news, with the rise of #MeToo and a better understanding of the hurdles women face in getting to the top spots in biopharma and health care. But what about women’s health? We looked back at our year of coverage and picked out 10 of our favorite stories.

Pregnancy

Pregnancy is a medical black box in many ways, including in drug safety. For ethical reasons, we don’t test medicines on pregnant women and fetuses, and when it comes to women’s diseases.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
STAT1 min read
STAT+: In Large Trial, Guardant Health’s Blood Test Detects Colon Cancer, But Less Reliably At Earliest Or Precancerous Stages
If approved, Guardant Health’s liquid biopsy is likely to be a strong new addition to colorectal cancer screening tools, particularly for patients who currently choose not to get screened.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An OptumRx Contract, 340B Dispute Resolution, And More
Cardinal Health announced its pharmaceutical distribution contracts with UnitedHealth's OptumRx unit will not be renewed after they expire in June.

Related Books & Audiobooks